Previous Close | 68.26 |
Open | 68.18 |
Bid | 67.72 x 100 |
Ask | 67.78 x 100 |
Day's Range | 67.68 - 68.35 |
52 Week Range | 60.47 - 76.56 |
Volume | |
Avg. Volume | 6,330,690 |
Market Cap | 210.053B |
Beta (5Y Monthly) | 0.17 |
PE Ratio (TTM) | 35.66 |
EPS (TTM) | 1.90 |
Earnings Date | N/A |
Forward Dividend & Yield | 1.45 (2.12%) |
Ex-Dividend Date | Feb 22, 2024 |
1y Target Est | 81.83 |
Subscribe to Yahoo Finance Plus to view Fair Value for AZN
While AbbVie (ABBV) is set to buy Landos Biopharma, Novo Nordisk (NVO) is set to acquire Cardior Pharmaceuticals. FDA approves J&J's (JNJ) and Merck's (MRK) PAH drugs.
Data from an early-stage study shows that patients who received Viking's (VKTX) orally-administered obesity drug lost up to 5.3% of their body weight after 28 days.
In the most recent trading session, Astrazeneca (AZN) closed at $66.33, indicating a +0.71% shift from the previous trading day.